BioConvergence LLC v. Emergent BioSolutions, Inc.

CourtDistrict Court, D. Maryland
DecidedJune 7, 2023
Docket1:21-cv-01959
StatusUnknown

This text of BioConvergence LLC v. Emergent BioSolutions, Inc. (BioConvergence LLC v. Emergent BioSolutions, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BioConvergence LLC v. Emergent BioSolutions, Inc., (D. Md. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

BIOCONVERGENCE LLC, d/b/a SINGOTA SOLUTIONS, * * Plaintiff, * v. * Civil Case No: 1:21-cv-01959-CCB EMERGENT BIOSOLUTIONS, INC. et al, * Defendants. * * * * * * * * * * * * MEMORANDUM OPINION AND ORDER This case was referred to the undersigned by Judge Blake of this Court on May 11, 2023, for discovery and all related scheduling. (ECF No. 57). This referral was prompted by two related motions for protective orders filed by Plaintiff, BioConvergence LLC d/b/a Singota Solutions (“Singota” or “Plaintiff”) on April 25, 2023. (ECF Nos. 51 & 52). This Memorandum Opinion and Order concerns Plaintiff’s Motion for Entry of Protective Order to Protect Confidential Information (ECF No. 51). Specifically, this Motion concerns Plaintiff’s objection to the dissemination of discovery material classified as “attorneys’-eyes- only” (“AEO”) to Defendants’ designated in-house counsel. The Court has reviewed the parties’ respective filings on the issue (ECF Nos. 51, 56, & 59). Furthermore, the Court held an in-person hearing on June 6, 2023. As set forth more fully below, Plaintiff’s Motion (ECF No. 51) is DENIED, and the parties shall submit a proposed protective order for the Court’s approval in compliance with this Memorandum Opinion and Order by June 14, 2023. I. BACKGROUND As indicated above, this Memorandum Opinion and Order addresses the first (ECF No. 51) of two discovery Motions which Plaintiff filed on April 25, 2023. (ECF Nos. 51 & 52). The Court has provided an overview of this case’s relevant facts and history in a separate filing addressing ECF No. 52.1 As such, the Court will not rearticulate the history of this case here. For purposes

of this Motion, it is sufficient to acknowledge that “[t]his litigation involves allegations that [Plaintiff’s] confidential information and trade-secret information was misappropriated by a former . . . employee [of Plaintiff] who went to work for Defendants.” (ECF No. 51 at p. 5).2 Put simply, “the parties are at an impasse regarding whether documents and information subject to the [AEO] designation can be accessed by [certain] in-house counsel[]” for Defendants. (ECF No. 56 at p. 1). Plaintiff maintains that it “cannot agree to produce its AEO materials to Defendants’ in-house counsel due to legitimate concerns regarding the protection of its confidential business information.” (ECF No. 51 at p. 1). Although Defendants employ in-house counsel, Plaintiff does not. Id. at p. 2. In its Motion, Plaintiff argued that Defendants’ “[i]n-house

counsel may have business related responsibilities and report to work with business personnel. Thus, it would be impossible for in-house counsel to separate its business responsibilities and its legal responsibilities in this litigation.” Id. at p. 3 (emphasis added). In turn, Defendants argued in their Opposition that Plaintiff is asking the Court to inappropriately “restrict in-house counsel’s access based solely upon their status as an employee of Defendants.” (ECF No. 56 at p. 3) (emphasis in original). Finally, in its Reply, Plaintiff argued that Defendants cannot show how

1 ECF No. 52 concerns Plaintiff’s objections to Defendants’ second amended notice of Fed. R. Civ. P. 30(b)(6) deposition. The Court’s Memorandum Opinion and Order addressing that motion will be filed along with this Memorandum Opinion and Order.

2 When the Court cites to a specific page number or range of page numbers, the Court is referring to the page numbers provided in the electronic filing stamps located at the top of every electronically filed document. they would be prejudiced without in-house counsel having access to AEO material, nor have Defendants provided the Court with any information regarding in-house counsel’s involvement in competitive decision-making. See (ECF No. 59). II. LEGAL STANDARD

“To prevent undue burden and expense, the court may[—for good cause—]issue a protective order ‘requiring that a trade secret or other confidential research, development, or commercial information not be revealed or be revealed only in a specified way.’” M–Edge Accessories LLC v. Amazon.com Inc., MJG-11-332, 2013 WL 12241898, at *2 (D. Md. May 14, 2013) (citing Fed. R. Civ. P. 26(c)(1)(G)); Layne Christensen Co. v. Purolite Co., 271 F.R.D. 240, 248 (D. Kan. 2010). “Under Rule 26, a party seeking to limit the manner in which information is disclosed to a competitor must show that the documents sought actually concern trade secrets or other confidential research, development, or commercial information, and that disclosure might be harmful.” Amazon.com Inc., 2013 WL 12241898 at *2 (citing Layne Christensen Co., 271 F.R.D. at 248–49). “If the requesting party meets this burden, ‘the burden then shifts to the party seeking

unrestricted disclosure to establish that disclosure is relevant and necessary to the action.’” Amazon.com Inc., 2013 WL 12241898 at *2 (quoting Layne Christensen Co., 271 F.R.D. at 248– 49). However, “the determination of whether a particular individual should have access to a competitor’s highly confidential documents turns on whether that individual is ‘involved in competitive decisionmaking[.]’” Amazon.com Inc., 2013 WL 12241898 at *3 (citing U.S. Steel Corp. v. U.S., 730 F.2d 1465, 1468, n.3 (Fed. Cir. 1984)). “The law on counsel’s access to confidential material is governed by the over-arching principles set-out in [U.S.] Steel Corp. v. [U.S.], 730 F.2d 1465 (Fed. Cir. 1984).” MedImmune, Inc. v. Centocor, Inc., 271 F. Supp. 2d 762, 773 (D. Md. 2003). “As pronounced by the Federal Circuit, the policy underlying a restriction on counsel’s access to confidential materials is the concern that counsel might inadvertently disclose the confidential material learned during the course of litigation.” Id. (citing U.S Steel Corp., 730 F.2d at 1468). “The competing interests to be evaluated in determining the outcome of such a dispute are one party’s right to broad discovery

and the other party’s ability to protect its confidential materials from misuse by competitors.” MedImmune, Inc., 271 F. Supp. 2d at 773 (citing Brown Bag Software v. Symantec Corp., 960 F.2d 1465, 1469–70 (9th Cir.), cert. denied sub nom., BB Asset Mgmt. v. Symantec Corp., 506 U.S. 869 (1992)). “The inquiry focuses on whether counsel can be deemed a ‘competitive decision- maker[,]’ which the Federal Circuit says is shorthand for ‘a counsel’s activities, association, and relationship with a client that is such as to involve counsel’s advice and participation in any or all of the client’s decisions (pricing, product design, etc.) made in light of similar corresponding information about a competitor.’” MedImmune, Inc., 271 F. Supp. 2d at 773 (quoting U.S. Steel Corp., 730 F.2d at 1468, n .3). “A counsel’s title as ‘in-house’ or ‘retained’ will not be dispositive on the issue.” MedImmune, Inc., 271 F. Supp. 2d at 773 (other citation omitted). “In addition to

determining whether a counsel is a competitive decision-maker, the Court must also analyze whether denying counsel access to confidential material would work substantial hardship on one of the parties.” Id. (other citation omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gulf Oil Co. v. Bernard
452 U.S. 89 (Supreme Court, 1981)
MedImmune, Inc. v. Centocor, Inc.
271 F. Supp. 2d 762 (D. Maryland, 2003)
MGP Ingredients, Inc. v. Mars, Inc.
245 F.R.D. 497 (D. Kansas, 2007)
Layne Christensen Co. v. Purolite Co.
271 F.R.D. 240 (D. Kansas, 2010)
Brown Bag Software v. Symantec Corp.
960 F.2d 1465 (Ninth Circuit, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
BioConvergence LLC v. Emergent BioSolutions, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/bioconvergence-llc-v-emergent-biosolutions-inc-mdd-2023.